Challenge:
SynCo needed a new corporate identity that would help it stand out among biopharmaceutical CMOs and allow prospective clients to focus immediately on the company’s strengths. This required re-branding across all SynCo’s external and internal communications.

Solution:
De Facto was tasked to develop and communicate a new corporate identity that would help it stand out among biopharmaceutical CMOs. Using brand research, we translated the services and values imperative to the customer’s needs - confidence and reliability - into a powerful message: ‘Trust us to make it right’. We also simultaneously engaged in a proactive media relations programme to reinforce this new message through the company’s track record of success.

Result:
Internal uptake was all-pervasive and prospective clients, even competitors, were highly positive of the new message and brand identity. Within three months, the PR programme had secured image-building articles in all the major publications read by SynCo’s target audiences.